BioSpace News Archive

Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats

Shionogi & Co., Ltd. announced the company is responding to the urgent global need for additional antimicrobial research and development by establishing its first discovery laboratory in the U.S., in San Diego, California.

June 3, 2024
·
9 min read
Scryb Announces Closing of Private Placement

Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) (“Scryb’’ or the “Company”), is pleased to announce that, further to its press releases of April 1, 2024 and May 9, 2024

June 3, 2024
·
4 min read
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS

June 3, 2024
·
3 min read
Press Releases

U.S. Pharmacy Benefit Management Market Size to Reach USD 853.50 Bn by 2033

June 3, 2024
·
12 min read
Biotech Beach

Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)

Crinetics Pharmaceuticals, Inc. announced initial findings from the development program of its second clinical product candidate, atumelnant*, a novel, once-daily oral adrenocorticotropic hormone receptor antagonist.

June 3, 2024
·
11 min read
Biotech Beach

Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today presented findings from its clinical development program evaluating oral, once-daily investigational paltusotine in acromegaly.

June 3, 2024
·
12 min read
Biotech Bay

Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform

Septerna today presented preclinical data from the company’s parathyroid hormone 1 receptor (PTH1R) program and its thyroid stimulating hormone receptor (TSHR) program which validate the application of the Native Complex Platform™ for drug discovery in endocrine disorders.

June 3, 2024
·
6 min read
Pharm Country

CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis

CMP Scientific, a leader in capillary electrophoresis-mass spectrometry technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics.

June 3, 2024
·
3 min read
Drug Development

Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise

Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, is presenting data from its pivotal IGNYTE-ESO trial

June 3, 2024
·
6 min read
Aurigene Pharmaceutical Services Limited, a global CRDMO, announces the opening of its biologics facility offering process development and clinical scale manufacturing capabilities

Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley

June 3, 2024
·
4 min read